Josh D. Epworth, MSN, ARNP, on Multiple Myeloma: Early Results From the PAVO Trial
Josh D. Epworth, MSN, ARNP, of the University of Washington Medical Center, discusses safety and efficacy data on subcutaneous daratumumab in patients with relapsed or refractory multiple myeloma (Abstract 1995).
